Lineage Cell Therapeutics Price Chart
Lineage Cell Therapeutics Volume Chart
Lineage Cell Therapeutics Market Segments
Regular Trading Hours
+0.00(+0.00%)
| Open | $1.59 |
|---|---|
| Close | $1.59 |
| Low | $1.58 |
| Low Change | -0.01 (-0.63%) |
| High | $1.64 |
| High Change | +0.05 (+3.14%) |
| Range | $0.06 |
| Volume | 269.686K |
| Dollar Volume | $428.80K |
Premarket
+0.03(+1.88%)
| Open | $1.60 |
|---|---|
| Close | $1.63 |
| Low | $1.60 |
| Low Change | 0.00 (0.00%) |
| High | $1.67 |
| High Change | +0.07 (+4.38%) |
| Range | $0.07 |
| Volume | 6.073K |
| Dollar Volume | $9.90K |
After Hours Yesterday
+0.03(+1.88%)
| Open | $1.60 |
|---|---|
| Close | $1.63 |
| Low | $1.60 |
| Low Change | 0.00 (0.00%) |
| High | $1.63 |
| High Change | +0.03 (+1.88%) |
| Range | $0.03 |
| Volume | 1.76K |
| Dollar Volume | $2.87K |
Regular Trading Hours Yesterday
+0.02(+1.27%)
| Open | $1.58 |
|---|---|
| Close | $1.60 |
| Low | $1.56 |
| Low Change | -0.02 (-1.27%) |
| High | $1.67 |
| High Change | +0.09 (+5.70%) |
| Range | $0.11 |
| Volume | 1.375M |
| Dollar Volume | $2.20M |
Premarket Yesterday
-0.08(-4.97%)
| Open | $1.61 |
|---|---|
| Close | $1.53 |
| Low | $1.47 |
| Low Change | -0.14 (-8.70%) |
| High | $1.61 |
| High Change | +0.00 (+0.00%) |
| Range | $0.14 |
| Volume | 27.476K |
| Dollar Volume | $42.04K |
Lineage Cell Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $1.66 |
|---|---|
| 10 Day Moving Average (SMA10) | $1.75 |
| 20 Day Moving Average (SMA20) | $1.79 |
| 50 Day Moving Average (SMA50) | $1.72 |
| 100 Day Moving Average (SMA100) | $1.73 |
| 200 Day Moving Average (SMA200) | $1.44 |
Lineage Cell Therapeutics Statistics
| Average Volume (30 Days) | 1.31M |
|---|---|
| P/E Ratio (Current) | -5.75 |
| EPS (Current) | -$0.28 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$19.44M |
| Cash Ratio | 3.59 |
| Current Ratio | 5.20 |
| Quick Ratio | 5.20 |
| Debt to Equity | 0.00 |
| Enterprise Value | $330.11M |
| EV to EBITDA | -15.66 |
| EV to Sales | 22.68 |
| Price to Book | 8.32 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 25.48 |
| Return on Assets | -0.56% |
| Return on Equity | -1.43% |
Lineage Cell Therapeutics Stock Splits
There have been no stock splits for Lineage Cell Therapeutics (LCTX).
Lineage Cell Therapeutics Dividends
There have been no dividends for Lineage Cell Therapeutics (LCTX).